FountainRx Revenue and Competitors

Morristown, TN

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • FountainRx's estimated annual revenue is currently $8.4M per year.(i)
  • FountainRx's estimated revenue per employee is $187,600

Employee Data

  • FountainRx has 45 Employees.(i)
  • FountainRx grew their employee count by 29% last year.

FountainRx's People

NameTitleEmail/Phone
1
Partner and Chief Pharmacy OfficerReveal Email/Phone
2
Chief Strategy OfficerReveal Email/Phone
3
VP Pharma RelationsReveal Email/Phone
4
Physician Relations ManagerReveal Email/Phone
5
Compounding Pharmacy ManagerReveal Email/Phone
6
Specialty Physician Relations ManagerReveal Email/Phone
7
Physician Relations ManagerReveal Email/Phone
8
Senior Sales SpecialistReveal Email/Phone
9
Pharmacist-in-ChargeReveal Email/Phone
10
Marketing CoordinatorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A525%N/AN/A
#2
$145.5M5170%$28.5MN/A
#3
$102.7M4220%N/AN/A
#4
$58.7M2556%N/AN/A
#5
$8.2M41-2%N/AN/A
#6
$22.5M11212%$23.6MN/A
#7
$5.6M244%N/AN/A
#8
$11.3M5928%N/AN/A
#9
$13.1M657%N/AN/A
#10
$7.6M3616%N/AN/A
Add Company

What Is FountainRx?

At FountainRx, we are committed to playing a key role in the health and healing of our patients. We lead with compassion, fervently serving our patients, providers and payers with integrity, excellence and stellar service. Our state-of-the-art pharmacy and extensive network have enabled us to become highly effective and patient-centric. We integrate knowledge and expertise to formulate creative and customized medication solutions, maximizing the potential for positive therapeutic outcomes while helping to reduce the overall cost of care to the healthcare system.

keywords:N/A

N/A

Total Funding

45

Number of Employees

$8.4M

Revenue (est)

29%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.5M455%N/A
#2
N/A4618%N/A
#3
$10.2M47-10%N/A
#4
$11.7M48-6%N/A
#5
$3.5M490%N/A